Every contract the U.S. government announced for Regeneron since Sep 25, 2026, with the money actually committed and what the stock did next.
| Date | Agency | Amount | Obligated | Type | Stock after | Official notice |
|---|---|---|---|---|---|---|
| Sep 25, 2026 | Health & Human Services | $278 M | $278 M | Modification | +1.0% | source ↗ |
| Inmazeb ebola therapeutics | ||||||
Since our tracking window began, the U.S. Department of War announced 1 contract for Regeneron totaling $278 M, of which $278 M is obligated (firm) money.
The awards came from: Health & Human Services.
Together they equal 0.34% of the company's market value. The stock moved +1.0% since the first contract in this window. Contracts are one factor among many; this is educational, not financial advice.
Educational content, not financial advice. Data: daily contract announcements of the U.S. Department of War (≥ $7.5 M), prices via Yahoo Finance.